-
1 Comment
Cryoport, Inc is currently in a long term uptrend where the price is trading 8.6% above its 200 day moving average.
From a valuation standpoint, the stock is 53.4% cheaper than other stocks from the Industrials sector with a price to sales ratio of 24.7.
Cryoport, Inc's total revenue rose by 423.3% to $48M since the same quarter in the previous year.
Its net income has dropped by 1116.8% to $-12M since the same quarter in the previous year.
Finally, its free cash flow fell by 3182.3% to $-14M since the same quarter in the previous year.
Based on the above factors, Cryoport, Inc gets an overall score of 3/5.
Industry | Integrated Freight & Logistics |
---|---|
Sector | Industrials |
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US2290503075 |
Market Cap | 292M |
---|---|
PE Ratio | None |
Target Price | 11.0556 |
Beta | 1.82 |
Dividend Yield | None |
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CYRX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025